Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Niannian Yiyang
- ·The full record, as it builds
Funding rounds
No funding rounds for Niannian Yiyang are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Niannian Yiyang
Provider of a next-generation health management service intended to scientifically delay ageing and help users proactively manage their health. The company offers advanced biotesting of DNA methylation, gut microbiota, and inflammatory factors, combined with personalised intervention programs, enabling health-conscious individuals to achieve measurable, sustainable, and effective anti-ageing results.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Niannian Yiyang doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Niannian Yiyang shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Niannian Yiyang in its N-PORT filings yet. We sweep new filings monthly.